165 results on '"de Giorgio A"'
Search Results
2. BOC.01.2: THE IMPACT OF UNNECESSARY GLUTEN-FREE DIET ON GUT MICROBIOTA
3. OC.11.8: SHORT- AND LONG-TERM RESULTS OF LIVER TRANSPLANTATION IN PATIENTS WITH ALCOHOLIC LIVER DISEASE (ALD) AND ACUTE ON CHRONIC LIVER FAILURE
4. Chronic non-allergic rhinitis with neutrophils is associated with higher acid exposure time: A pH-impedance monitoring study
5. Therapeutic options for coeliac disease: What else beyond gluten-free diet?
6. Long term outcome of patients with hepatocellular carcinoma treated with transarterial radioembolization
7. Seronegative celiac disease: Shedding light on an obscure clinical entity
8. Clinical impact and treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after liver transplant (LT). The role of transjugular intrahepatic porto-systemic shunt (TIPS)
9. OC.15.2 SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
10. PC.01.9 HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE
11. OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
12. Anemia in non-celiac wheat sensitivity: Prevalence and associated clinical and laboratory features
13. OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
14. Audit of digestive complaints and psychopathological traits in patients with eating disorders: A prospective study
15. OC.15.2 SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
16. Clinical impact and treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after liver transplant (LT). The role of transjugular intrahepatic porto-systemic shunt (TIPS)
17. TKIs treatment for HCC before Liver transplantation: an ELITA/ELTR collaborative study
18. Myenteric neuronal loss in rats with experimental colitis: Role of tissue transglutaminase-induced apoptosis
19. AFP at transplant is associated with a higher risk of HCC recurrence after liver transplantation for patients meeting Milano criteria
20. Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
21. AFP at transplant is associated with a higher risk of HCC recurrence after liver transplantation for patients meeting Milano criteria
22. Anti-ganglioside antibodies in coeliac disease with neurological disorders
23. Gastro-oesophageal reflux and interstitial lung disease
24. Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus
25. Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation
26. Unsolved problems in the management of patients with gastro-oesophageal reflux disease
27. Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders
28. Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms
29. 5-HT 4 Receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract
30. Safety and effectiveness of Regorafenib in recurrent HCC after liver transplantation and progression on Sorafenib: a real-life multicentre study
31. Upper gastrointestinal bleeding due to duodenal metastasis from primary lung carcinoma
32. Audit of digestive complaints and psychopathological traits in patients with eating disorders: A prospective study
33. Safety and effectiveness of Regorafenib in recurrent HCC after liver transplantation and progression on Sorafenib: a real-life multicentre study
34. Clinical use of manometry for the diagnosis of intestinal motor abnormalities
35. Validation of Liver Imaging Reporting and Data System (LI-RADS) Version 2014
36. Validation of Liver Imaging Reporting and Data System (LI-RADS) Version 2014
37. Early changes in non invasive assessment of liver fibrosis in hepatitis C virus-infected patients treated with DAAs: Preliminary reports
38. Validation of the Bolondi stratification for intermediate stage hepatocellular carcinoma (HCC). Clinical and therapeutical implications
39. HCC onset and features among chronic hepatitis B patients treated with nucleos(t)ide analogues
40. Early changes in non-invasive assessment of liver fibrosis in hepatitis C virus-infected patients treated with DAAs: Preliminary reports
41. 5-HT4 Receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract
42. Validation of the Bolondi stratification for intermediate stage hepatocellular carcinoma (HCC). Clinical and therapeutical implications
43. HCC onset and features among chronic hepatitis B patients treated with nucleos(t)ide analogues
44. Early changes in non-invasive assessment of liver fibrosis in hepatitis C virus-infected patients treated with DAAs: Preliminary reports
45. Treatment of advanced hepatocellular carcinoma (HCC): a single centre cost analysis of yttrium 90 trans-arterial radio-embolization (TARE) versus Sorafenib
46. Prognostic factors affecting 1-year hepatocellular carcinoma (HCC) progression in liver transplantation candidates
47. Treatment of advanced hepatocellular carcinoma (HCC): a single centre cost analysis of yttrium 90 trans-arterial radio-embolization (TARE) versus Sorafenib
48. OC.02.4 INTERFERON-GAMMA INTERPLAY WITH SEROTONIN METABOLISM AND MUCOSAL PERMEABILITY IN IRRITABLE BOWEL SYNDROME
49. PP4 PERFORMANCE OF ANTIBODIES TO DEAMIDATED GLIADIN PEPTIDES IN THE DIAGNOSIS OF CELIAC DISEASE IN INFANCY
50. OC.02.4 INTERFERON-GAMMA INTERPLAY WITH SEROTONIN METABOLISM AND MUCOSAL PERMEABILITY IN IRRITABLE BOWEL SYNDROME
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.